Health
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone – Medical Xpress
Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had…
Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
“Dexamethasone is a potent corticosteroid that is often prescribed to patients with glioblastoma to treat symptoms related to cerebral edema, or swelling in the brain,” said…
-
Noosa News21 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General24 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Noosa News18 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
Noosa News22 hours agoMan dead after breaking into childcare centre